Oxford Ledge
Search
No licensed closing price on file for MANE. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
Veradermics, Incorporated (NYSE: MANE) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-19 21:19 UTC.
The company is a dermatologist-founded biopharmaceutical firm developing treatments for hair loss conditions that affect millions of people. The company's lead product is VDPHL01, an oral, non-hormonal formulation designed to address shortcomings in current hair loss treatments, including slow onset of effects and limited options for women. VDPHL01 is based on minoxidil, a proven hair growth agent, formulated as an extended-release medication intended to improve hair regrowth while avoiding cardiac side effects seen with existing treatments.
Summarized from Veradermics, Incorporated’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
Charts, 10-year financials, peer comparison, screening and portfolio tracking for MANE and 5,000+ tickers.
Create a free account — keep MANEGET /api/data?ticker=MANE
This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt